Skip to main content
logo
Biomark Diagnostics Inc. (BMKDF)
OTCMKTS · Delayed Price · Currency is USD
0.2385
0.00 (0.00%)
Oct 26, 2025, 8:00 PM EDT

Biomark Diagnostics Revenue

Biomark Diagnostics had revenue of 38.99K CAD in the quarter ending June 30, 2025, with 1.77% growth. This brings the company's revenue in the last twelve months to 154.90K, down -4.26% year-over-year. In the fiscal year ending March 31, 2025, Biomark Diagnostics had annual revenue of 154.22K, down -5.52%.

Revenue (ttm)
154.90K CAD
Revenue Growth
-4.26%
P/S Ratio
206.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
23.41M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025154.22K-9.00K-5.52%
Mar 31, 2024163.22K9.73K6.34%
Mar 31, 2023153.49K109.56K249.38%
Mar 31, 202243.93K--
Mar 31, 2021---
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Jushi Holdings256.36M
Glass House Brands221.55M
Elite Pharmaceuticals105.45M
Silence Therapeutics27.17M
Nuo Therapeutics1.95M
Northwest Biotherapeutics1.09M
Revenue Rankings

Biomark Diagnostics News

More News